CH could be classified into focal or diffuse forms and is characterized by increased insulin secretion by pancreatic beta-cells, causing hypoglycemia associated with low/normal levels of ketones and fatty acids, absence of metabolic acidosis, and positive glycemic response to glucagon. The gene discussed is INS; the disease is cyclic hematopoiesis.